Study on the evolution of the traditional Chinese Medicine syndromes of primary nephrotic syndrome treated with rituximab in children and the prognosis

ObjectiveTo prospectively observe changes in the traditional Chinese medicine （TCM） syndromes in children with primary nephrotic syndrome（PNS） before and after the rituximab （RTX） treatment， thus summarizing evolution patterns and prognostic impact of TCM syndromes types.MethodEighty-nine PNS childr...

Full description

Bibliographic Details
Published in:	Linchuang shenzangbing zazhi
Main Authors:	Ai Yi-ying, Wu Rui-bo, Wen Zi-long, Xu Kai-si
Format:	Article
Language:	Chinese
Published:	Editorial Department of Journal of Clinical Nephrology 2025-06-01
Subjects:	Primary nephrotic syndrome in children Rituximab TCM syndromes Prognosis
Online Access:	http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2025.06.003

Similar Items

Efficacy and Safety of Subcutaneous Rituximab in Idiopathic Nephrotic Syndrome
by: Paolo Cravedi, et al.
Published: (2024-11-01)

Effectiveness of rituximab in nephrotic syndrome treatment
by: Katarzyna Popko, et al.
Published: (2017-10-01)

Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
by: Yiyun Song, et al.
Published: (2023-07-01)

A meta-analysis of the efficacy of rituximab in the treatment of refractory nephrotic syndrome
by: Liu Wu, et al.
Published: (2021-01-01)

Application and efficacy analysis of rituximab in the treatment of childhood primary nephrotic syndrome in Ningxia
by: Wu Yang, et al.
Published: (2024-02-01)

Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth
by: Rezan Topaloğlu, et al.
Published: (2019-07-01)

Rituximab therapy in adults with steroid-dependent nephrotic syndrome
by: Hongzhen Zhong, et al.
Published: (2019-10-01)

Rituximab-induced serum sickness and anaphylaxis in a child with nephrotic syndrome
by: Meral Torun Bayram, et al.
Published: (2020-10-01)

Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome
by: Ji Hyun Kim, et al.
Published: (2017-09-01)

Rituximab in the treatment of refractory nephrotic syndrome with massive pleural effusion: one case report
by: Zhang Shuo-fan, et al.
Published: (2021-01-01)

Long-term efficacy of Rituximab in steroid dependent and frequent relapsing adult nephrotic syndrome
by: Omri Feder, et al.
Published: (2025-03-01)

Research advances of rituximab in the treatment of children with frequent relapse or steroid-dependent nephrotic syndrome
by: Wen-jing Kang, et al.
Published: (2024-10-01)

Effects of Rituximab Including Long-term Maintenance Therapy in Children with Nephrotic Syndrome in a Single Center of Korea
by: Seong Heon Kim, et al.
Published: (2018-04-01)

Rituximab Administration to Treat Nephrotic Syndrome in Children: 2-Year Follow-Up
by: Dmytro Ivanov, et al.
Published: (2024-11-01)

The efficacy of rituximab in treatment of childhood steroid resistant and steroid dependent nephrotic syndrome: a systematic review and Meta-analysis
by: Hamid Mohammadjafar, et al.
Published: (2013-05-01)

The efficacy and dynamic changes of immune function of rituximab with mycophenolate mofetil in the treatment of steroid-dependent /frequently relapsing nephrotic syndrome: a retrospective follow-up study
by: Songlei Gu, et al.
Published: (2025-04-01)

The efficacy and safety of rituximab in the maintenance treatment of first-episode minimal change nephrotic syndrome
by: Wang Ling, et al.
Published: (2025-05-01)

Nephrotic syndrome; is rituximab the light at the end of the tunnel in the treatment of adult steroid-dependent minimal change disease and focal segmental glomerulosclerosis?
by: Andreas Kronbichler, et al.
Published: (2014-01-01)

Clinical case of steroid-dependent nephrotic syndrome in a child
by: Ye. Lagodych, et al.
Published: (2023-06-01)

Early Rituximab as an Add-On Therapy in Children With the Initial Episode of Nephrotic Syndrome
by: Jialu Liu, et al.
Published: (2024-05-01)

Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial)
by: China Nagano, et al.
Published: (2019-08-01)

Low-dose rituximab followed by mycophenolate mofetil for steroid-dependent/frequently relapsing nephrotic syndrome in children: a case series
by: Jide Song, et al.
Published: (2025-08-01)

Steroid-resistant minimal change nephrotic syndrome associated with thymoma treated effectively with rituximab following thymectomy and cyclosporine: a case report
by: Yusaku Watanabe, et al.
Published: (2024-02-01)

Combined Rituximab and Daratumumab Treatment in Difficult-to-Treat Nephrotic Syndrome Cases
by: Andrea Angeletti, et al.
Published: (2024-06-01)

Efficacy and safety of rituximab in children with steroid-dependent or frequently relapsing nephrotic syndrome: a meta-analysis of randomized controlled trials
by: Ningxin Luo, et al.
Published: (2023-02-01)

Rituximab-associated adverse events in nephrotic syndrome: A systematic review and meta-analysis
by: Zixian Yu, et al.
Published: (2025-01-01)

Combination of rituximab and low-dose glucocorticoids for idiopathic refractory nephrotic syndrome with MCD/FSGS: a single-center prospective cohort study
by: Aikeda Yimamuyushan, et al.
Published: (2024-12-01)

Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study
by: Xiaoyan Ma, et al.
Published: (2023-12-01)

Advancing the Treatment of Adult Steroid-Resistant Nephrotic Syndrome: The Role of Rituximab
by: Dmytro Ivanov, et al.
Published: (2025-03-01)

Use of rituximab in pediatric patients with steroidresistant nephrotic syndrome. A single center study
by: Serna-Higuita, Lina María, et al.
Published: (2015-01-01)

Rituximab versus tacrolimus as corticosteroid-sparing therapy for children with steroid-dependent nephrotic syndrome: A systematic review and meta-analysis of randomized and nonrandomized controlled trials
by: Jessica Felicia Ang, et al.
Published: (2024-04-01)

Therapeutic efficacy of low-dose rituximab for steroid-dependent minimal-change nephrotic syndrome in adults
by: Li Xiao-wei, et al.
Published: (2021-01-01)

The efficacy and safety of rituximab monotherapy in the new onset pediatric idiopathic nephrotic syndrome: a randomized controlled clinical trial
by: Ai-Qin Sheng, et al.
Published: (2025-12-01)

Long Term Evaluations of First Single-dose Rituximab in Children with Steroid-Dependent Minimal-Change Nephrotic Syndrome
by: Xiao-Ling Niu, et al.
Published: (2024-12-01)

Combined Methylprednisolone Pulse Therapy plus Rituximab for Treating a Rare Juvenile Steroid-Resistant Nephrotic Syndrome with Cerebral Venous Sinus Thrombosis: A Case Report
by: Hader I. Sakr, et al.
Published: (2022-11-01)

Kinetic-pharmacodynamic model to predict post-rituximab B-cell repletion as a predictor of relapse in pediatric idiopathic nephrotic syndrome
by: Ziwei Li, et al.
Published: (2025-01-01)

C1q nephropathy in a patient complicated with nephrotic syndrome and refractory to steroid therapy
by: Yun-Hong Yang, et al.
Published: (2020-02-01)

Two cases of idiopathic membranous nephropathy treated with rituximab
by: Jae Young Yoon, et al.
Published: (2013-09-01)

Treatment of nephrotic syndrome with anti-CD20 therapies in pregnancy: a case series and review of the literature
by: Pierre-Alexis Gauci, et al.
Published: (2025-12-01)

Combined impact of rituximab and target care on efficacy, quality of life, adverse reactions and recurrence rate in children with nephrotic syndrome: a randomized controlled trial
by: Lanfen He, et al.
Published: (2025-09-01)